News & Perspective

Jun 15, 2011

Jun 15, 2011

Panel calls for refining, paring select-agent list

(CIDRAP News) – A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.

Jun 10, 2011

Jun 10, 2011

Germans target sprouts in E coli outbreak, clear other foods

(CIDRAP News) – German government officials today lifted their recommendation against eating cucumbers, tomatoes, and lettuce, and showcased evidence that puts sprouts front and center in their investigation of a massive Escherichia coli outbreak, though the outbreak strain has not yet been found in sprouts.

May 12, 2011

May 12, 2011

NRC seeks changes in US vaccine program for biodefense workers

(CIDRAP News) – A report from the National Research Council (NRC) calls for some changes in a US Army immunization program for lab researchers who work with dangerous pathogens, saying the vaccines need to be made more accessible to civilian scientists.

Mar 16, 2011

Mar 16, 2011

HHS: 386 injury claims filed over H1N1 countermeasures

Editor's note: This story was revised Mar 17 to include additional information about the number of claims filed and processing steps.

(CIDRAP News) – The US Department of Health and Human Services (HHS) has so far received 386 claims of injuries related to the 2009 pandemic H1N1 vaccine and related pandemic countermeasures, HHS officials reported today.

Mar 18, 2010

Feb 12, 2010

Feb 12, 2010

Report: For biodefense, US needs closer ties to industry

(CIDRAP News) – The US government needs much closer collaboration with private industry—like the arrangements used in building aircraft carriers and putting men on the moon—in order to improve the nation's medical defenses against biological, chemical, radiological, and nuclear threats, says a report from a federal advisory panel.

Sep 11, 2008

Sep 11, 2008

Firm wins $65 million contract for botulism treatments

(CIDRAP News) – Xoma Ltd., a Berkeley, Calif., pharmaceutical company, recently announced that it received a $65 million multiyear federal contract to fund work on botulinum antitoxins, one of which it hopes to put through safety and efficacy tests starting in 2009.

Jul 29, 2008

Jul 29, 2008

Anthrax vaccine maker wins NIAID grants

(CIDRAP News) – Emergent BioSolutions Inc. recently announced it had secured two federal grants totaling $4.5 million for development of its botulism and next-generation anthrax vaccine candidates.

Emergent, maker of the nation's only licensed anthrax vaccine, announced the grants from the National Institute of Allergy and Infectious Diseases (NIAID) in a Jul 24 news release.

Pages

Sort Results

 

Narrow results

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»